Unknown

Dataset Information

0

Desmethyl Macrolides: Synthesis and Evaluation of 4,10-Didesmethyl Telithromycin.


ABSTRACT: Novel sources of antibiotics are required to keep pace with the inevitable onset of bacterial resistance. Continuing with our macrolide desmethylation strategy as a source of new antibiotics, we report the total synthesis, molecular modeling and biological evaluation of 4,10-didesmethyl telithromycin (4), a novel desmethyl analogue of the 3rd-generation drug telithromycin (2). Telithromycin is an FDA-approved ketolide antibiotic derived from erythromycin (1). We found 4,10-didesmethyl telithromycin (4) to be four times more active than previously prepared 4,8,10-tridesmethyl congener (3) in MIC assays. While less potent than telithromycin (2), the inclusion of the C-8 methyl group has improved biological activity suggesting it plays an important role in antibiotic function.

SUBMITTER: Velvadapu V 

PROVIDER: S-EPMC3374412 | BioStudies | 2012-01-01

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC3763958 | BioStudies
2011-01-01 | S-EPMC3105755 | BioStudies
2011-01-01 | S-EPMC3170427 | BioStudies
2014-01-01 | S-EPMC4160760 | BioStudies
2013-01-01 | S-EPMC3901159 | BioStudies
2008-01-01 | S-EPMC2597235 | BioStudies
2003-01-01 | S-EPMC164882 | BioStudies
1000-01-01 | S-EPMC3367204 | BioStudies
2015-01-01 | S-EPMC4432155 | BioStudies
1000-01-01 | S-EPMC4190632 | BioStudies